HOME >> MEDICINE >> NEWS
Lack of funds hampering important child health study

US Congress should boost funding for an important study to identify the risk factors for childhood chronic disease, states an editorial in this week's issue of THE LANCET.

Environmental factors have a crucial role in determining the health of the world's 2.3 billion children. But exactly which risk factors contribute to childhood chronic disease is often unknown. The National Children's Study aims to track the health of 100,000 children across the USA from birth to their 21st birthday. The study will look at the environmental--including physical, chemical, biological, and psycho-social--influences on children's health and development. The researchers estimate that they will need US$2.7 billion over 25 years, but they have hit problems securing the necessary funds. The study has already been delayed by a year. For the 2005 fiscal year US Congress appropriated less than half the $27 million the researchers were counting on, and for the fiscal year 2006 President Bush has requested that Congress appropriate only $12 million--far less that the study needs to stay on track.

The Lancet comments: "American children are more likely than ever to develop chronic diseases such as obesity, diabetes, asthma, and behavioural disorders. According to one estimate, the annual disease burden from the ten most common health problems that afflict children is around $400 billion a year in the USA alone. From a purely economic point of view, therefore, the National Children's Study could pay for itself many times over if it reduces this burden by as little as 1% a yearUS Congress needs to have the long-term vision to leave a legacy to help future generations of children, not just in the USA but throughout the world."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
19-May-2005


Page: 1

Related medicine news :

1. Help the Aged funds the University of Nottingham to research pain affecting older people
2. $15M Northwestern grant funds heart research
3. Rotary funds new research
4. NHGRI funds assessment of public attitudes about population-based studies on genes and environment
5. Estate of fashion designer Geoffrey Beene donates funds to Memorial Sloan-Kettering Cancer Center
6. NIH funds $2 million magnetic resonance system at Yale
7. $5.8 million funds 2 new studies on best treatments for ADHD
8. $10 million gift funds innovative predictive health study
9. Rice, M. D. Anderson win funds for bench to bed training
10. $4.5 million CDC grant funds Yale Center for Public Health Preparedness
11. GlaxoSmithKline funds $1.65 million effort for UNC-Duke public health care partnership

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lack funds hampering important child health study

(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular North ... NA’s cyclotron sites and research and development facilities. , “We are excited ... a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Government Programs, with accountability for overall performance of the company’s Medicare and Federal ... focus of Cambia’s strategy to deliver better health for members. In this role, ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
(Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, Inc. ... a strategic collaboration to discover and develop antisense ... new collaboration builds on a broad existing relationship ... approach in these therapeutic areas using novel RNA-targeted ... use of its antisense technology to diseases of ...
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
Cached News: